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Magnesium induces neuronal apoptosis by
suppressing excitability
WH Dribben1, LN Eisenman2 and S Mennerick*,3

In clinical obstetrics, magnesium sulfate (MgSO4) use is widespread, but effects on brain development are unknown. Many
agents that depress neuronal excitability increase developmental neuroapoptosis. In this study, we used dissociated cultures of
rodent hippocampus to examine the effects of Mgþþ on excitability and survival. Mgþþ-induced caspase-3-associated cell loss
at clinically relevant concentrations. Whole-cell patch-clamp techniques measured Mgþþ effects on action potential threshold,
action potential peak amplitude, spike number and changes in resting membrane potential. Mgþþ depolarized action potential
threshold, presumably from surface charge screening effects on voltage-gated sodium channels. Mgþþ also decreased the
number of action potentials in response to ﬁxed current injection without affecting action potential peak amplitude. Surprisingly,
Mgþþ also depolarized neuronal resting potential in a concentration-dependent manner with a þ 5.2 mV shift at 10 mM. Voltage
ramps suggested that Mgþþ blocked a potassium conductance contributing to the resting potential. In spite of this depolarizing
effect of Mgþþ, the net inhibitory effect of Mgþþ nearly completely silenced neuronal network activity measured with
multielectrode array recordings. We conclude that although Mgþþ has complex effects on cellular excitability, the overall
inhibitory inﬂuence of Mgþþ decreases neuronal survival. Taken together with recent in vivo evidence, our results suggest that
caution may be warranted in the use of Mgþþ in clinical obstetrics and neonatology.
Cell Death and Disease (2010) 1, e63; doi:10.1038/cddis.2010.39; published online 12 August 2010
Subject Category: Neuroscience

Magnesium sulfate (MgSO4) has been used in clinical
obstetrics for over 70 years to treat pre-eclampsia/eclampsia
and preterm labor, conditions that complicate approximately 3
and 12.4% pregnancies, respectively, in the United States
each year.1 Currently, MgSO4 is the standard of care for
preventing and treating eclamptic seizures, and although its
safety and effectiveness as a tocolytic is controversial,2,3 it is
estimated that over 150 000 women in the United States
receive tocolytic therapy at or before 34 weeks of gestation
yearly, with MgSO4 used as a ﬁrst line of treatment in the
majority of cases.4,5 Although MgSO4 has generally been
accepted as being safe with no adverse effects in neonates,
no studies have addressed whether the exposure of normal
developing brains to high concentrations of Mgþþ has any
deleterious effects or consequences.
In contrast, Mgþþ has been studied extensively as a
potential neuroprotectant to prevent or improve outcomes of
brain injury resulting from perinatal hypoxia/ischemia such as
encephalopathy, intraventricular hemorrhage, periventricular
leucomalacia and cerebral palsy.6,7 However, the safety and
neuroprotective efﬁcacy of Mgþþ for premature, at-risk
neonates remains controversial.8 Recent reviews evaluating
the use of MgSO4 for neuroprotection of the fetus or use
as a tocolytic in women at risk for preterm birth concluded
that neuroprotective effects have not been established;

MgSO4 is ineffective at delaying or preventing preterm
birth and may actually increase neonatal morbidity and
mortality.2,9
Magnesium is second only to potassium in abundance as
an intracellular cation in the human body, and Mgþþ
participates in many cellular functions, including energy
production, synaptic neurotransmission and intracellular
signaling. Mgþþ blocks N-methyl-D-aspartate (NMDA) glutamate receptor ion channels, preventing ion ﬂow at typical
neuronal resting potentials.10 Divalent cations, including
Mgþþ at mM concentrations, decrease the activation of
voltage-gated channels through surface charge screening
effects,11–14 thereby reducing neuronal excitability. Mgþþ at
high extracellular concentrations also blocks Caþþ inﬂux and
diminishes synaptic transmission.15 Tocolytic actions apparently result from reduced myometrial contractility through
extra- and intracellular Mgþþ actions.16 However, supraphysiological Mgþþ also blocks potassium conductances and
g-aminobutyric acid (GABA)A receptors.17–19 Recent
evidence suggests that relief from long-term Mgþþ-induced
inhibition might result in homeostatic increases in long-term
potentiation and plasticity.20 Therefore, at supraphysiological
concentrations, Mgþþ may have complex actions on neuronal
excitability, and it is not clear whether net excitation or
inhibition will prevail during prolonged incubation.
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Compounds that inhibit neuronal activity, including NMDA
antagonists and calcium channel blockers, trigger widespread
apoptotic neurodegeneration in the developing brain during
the window of vulnerability (mice and rats 0–14 days
postnatally).21–23 In rodents, this critical period roughly
corresponds to the third trimester of human development,
when MgSO4 exposure typically occurs in humans.24 If Mgþþ
sufﬁciently inhibits neurons, Mgþþ administration to young
animals might increase developmental neuroapoptosis.
Indeed, we showed that in vivo MgSO4 induces widespread
central nervous system neuroapoptosis at postnatal day 3
and 7, but not postnatal day 14.25 This work did not explicitly
investigate whether Mgþþ acted directly or indirectly on
susceptible target neurons, a question to which in vitro
preparations are particularly well suited.
Given the complex cellular actions of Mgþþ on excitability
noted above and questions regarding whether Mgþþ directly
causes neuronal death, we examined survival in vitro, coupled
with eletrophysiological studies to test effects of Mgþþ on
excitability of neurons. For these mechanistic studies, we
exploited a primary culture preparation of rodent hippocampal
neurons.

Results
Survival effects/activated caspase-3 neurons. We found
that both MgSO4 and MgCl2 at concentrations of 5 and
10 mM induced death of hippocampal neurons relative to
control cultures (Figures 1a and b). Fewer neurons were
observed in treated cultures versus controls, and cellular
proﬁles of the dying neurons were often visible and
characterized by condensed, fragmented nuclei, as is often
associated with apoptotic cell death.21 MgSO4 and MgCl2
both had strong negative effects on survival at 5 mM and
at 10 mM added Mgþþ (Figure 1b). This places the
concentration at which Mgþþ kills neurons in the range in
which it has important effects on ion channels and is clinically
relevant.26 On the basis of the signiﬁcant degree of cell
death produced at concentrations of 5 and 10 mM of MgSO4,
we examined survival in a concentration-response study
comparing 1, 2.5 and 5 mM. In these studies (Figure 1c),
a trend of neuronal loss occurred with concentrations as low
as 1 mM of added MgSO4 (P ¼ 0.07). This trend became
statistically signiﬁcant at 2.5 and 5 mM above control
conditions (Figure 1c).
MgSO4 induces a wave of apoptotic neurodegeneration in
the neonatal mouse brain,25 in part deﬁned by activation of
caspase-3, an effector caspase in many types of neuronal
apoptosis.27 To determine if Mgþþ exposed neurons in vitro
undergo apoptotic changes and to positively identify dying
neurons, we immunostained the hippocampal cultures for
activated caspase-3. Immunostaining for activated caspase-3
has advantages over other measures of caspase activity
because it identiﬁes the cell type containing the activated
enzyme (in our case hippocampal neurons). Cell-type
identiﬁcation is a useful feature in our mixed culture of
astrocytes and neurons. We immunostained cells under
control conditions and cultures treated with 5 and 10 mM
additional MgSO4 for 3 days starting at 6 days in vitro.
Cell Death and Disease

Figure 1 Mgþþ decreases neuronal survival in primary hippocampal cultures.
(a) Phase-contrast photomicrograph showing healthy neurons (examples indicated
with arrows) used in cell counts. (b) Summary of counts from randomly selected
ﬁelds from dishes treated with MgSO4 or MgCl2 at the indicated concentrations.
Counts were normalized to counts from control sibling cultures (n ¼ 5 experiments
on independent platings). Mgþþ treatment was from day in vitro 5 through day
in vitro 10. (c) Summary of tests of lower MgSO4 concentrations on percent survival
relative to control. Although this set of cultures was slightly less susceptible to
effects of 5 mM Mgþþ compared with the cultures in (a), concentrations as low as
1 mM above control produced a signiﬁcant decrease in survival when compared with
control. Bars represent the means ± S.E.M. (n ¼ 6). *Po0.05; ***Po0.001

Apoptosis in response to activity blockade in vitro shows
signiﬁcantly increased caspase-3 staining in susceptible cells,
and Mgþþ produced a concentration-dependent increase
in the percentage of immunoreactive neurons in cultures
(Figure 2), similar to a variety of treatments that inhibit
neuronal activity.28,29 The absolute mean numbers of healthy
cells in the control versus treated groups were similar
(68.8±22.8 cells per control; 64.1±20.5 cells per 5 mM;
and 64.4±26.7 cells per 10 mM). This similarity resulted from
the early evaluation of the cultures at 3 days after MgSO4
treatment (Figure 2) versus the 6 days after treatment
evaluation in Figure 1 (see also Moulder et al.28). Both the
5 and 10 mM MgSO4 groups showed signiﬁcantly higher
percentages of caspase-3-positive cells relative to sibling
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Figure 2 More neurons show caspase-3 immunoreactivity in Mgþþ-treated cultures. (a) Control ﬁeld showing healthy neurons negative for activated caspase-3
immunoreactivity. (b) Field from a sibling Mgþþ-treated culture showing a neuron positive for activated caspase-3 (arrow). (c) Bar graphs summarize the percentage of
caspase-3-positive cells relative to healthy cells from the same ﬁelds. Both MgSO4 concentrations (5 and 10 mM) signiﬁcantly increased the percentage of apoptotic neurons
over control (n ¼ 5 experiments). (d) Summary of additional experiments designed to test protection by KCl incubation. KCl alone showed a trend of protection against
attritional neuronal loss and reduced the percentage of immunoreactivity to control levels in conjunction with Mgþþ exposure (n ¼ 5). *Po0.05; **Po0.01

controls (Figures 2c and d). The low absolute percentages of
caspase-3 immunoreactive neurons reﬂect the slow overall
loss of neurons, combined with transient caspase-3 immunoreactivity in individual neurons. A snapshot of caspase-3
immunoreactivity at any time point during the progressive loss
of neurons produces only a minority of positive cells.28,29
Chronic incubation of neurons with elevated concentrations
of KCl in the culture medium has been shown to protect
neurons from apoptotic cell death resulting from over-inhibition and from neurotrophic factor deprivation.23,28–31 KCl
depolarization is thought to prevent apoptosis by moderately
increasing intracellular Ca2 þ concentration.30 If Mgþþ acts by
decreasing neuronal activity, we would hypothesize that
treatment with KCl would counteract the effect of Mgþþ. In
contrast, if Mgþþ acted by other mechanisms, such as overexcitation, we might expect that KCl depolarization should
exacerbate the death. Therefore, to help further clarify the
nature of Mgþþ-induced neuronal death in vitro, we tested the
effect of 30 mM KCl on caspase-associated cell death induced
by Mgþþ. We found that KCl signiﬁcantly protected
against both spontaneous neuronal death and against
cell death induced by MgSO4 (Figure 2d). As shown in the
previous experiments, comparison of control versus MgSO4

showed signiﬁcantly increased activated caspase-3 presence. Comparison of Figures 2c and d shows considerable
variability in the amount of attrition-related apoptosis among
control cultures of different platings (B8% in Figure 2c versus
B2% in Figure 2d). Although all the factors participating in
the level of background apoptosis are not fully understood, the
Mgþþ-induced increase in caspase-3 immunoreactivity was
robust in the context of both lower and higher attritional loss.
Electrophysiology. To determine the effects of Mgþþ on
the excitability of hippocampal neurons, electrophysiology
experiments were performed with the same concentrations
of MgCl2 as the survival experiments (2.5, 5 and 10 mM).
MgCl2, rather than MgSO4, was used in the electrophysiology experiments because chloride salts are routinely used
in culture electrophysiology. As we predicted a net reduction
of excitability by Mgþþ based on our survival studies,
we compared the effects of escalating concentrations of
tetrodotoxin (TTX), a highly selective antagonist of voltagegated sodium channels with well deﬁned effects on
excitability.32 TTX silencing kills neurons in hippocampal
culture through apoptosis over a similar time course as that
of Mgþþ,28,29 so it served as a relevant comparator.
Cell Death and Disease
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In current-clamp mode, a 20 ms current pulse of þ 70 to
þ 220 pA was used to initiate action potentials. Current
amplitudes well beyond the rheobase of the cell were used
to help ensure that spiking was elicited by a ﬁxed current
amplitude, in spite of the reduced excitability anticipated with
Mgþþ and TTX application. Traces were recorded and
analyzed for action potential threshold, action potential peak
amplitude, spike number and changes in resting membrane
potential (Vm).
Figure 3 shows that there was a concentration-dependent
increase in action potential thresholds with Mgþþ treatment
(Figures 3a and b), which resulted in a decrease in excitability,
measured as the number of spikes elicited by the ﬁxed current
injection (Figure 3c). The effect on spike initiation became so
severe at 10 mM Mgþþ that in two cells we were unable to
evoke action potentials at this concentration. TTX (30 nM)
also signiﬁcantly depolarized threshold (Figure 4a). Quantitatively, the effect of 30 nM TTX on action potential threshold
was similar to the effect of 2.5 and 5 mM Mgþþ, with stronger
effects of 60 nM and 90 nM TTX (Po0.001) compared with
30 nM.

Mgþþ did not signiﬁcantly affect the peak amplitude of
action potentials except at the highest concentration (10 mM).
However, the change in maximum slope and peak amplitude
of the ﬁrst derivative of the action potential (Figures 3b and 4)
is consistent with a decreased availability and activation of
Na þ channels and subsequent shift in threshold.33 In
contrast, TTX at concentrations of 30 nM (Po0.01) and
higher (Po0.001) signiﬁcantly decreased the amplitude of
action potentials (Figure 4c). This was expected because of
the direct blockade of sodium channels by TTX. Mgþþ also
induced a concentration-dependent decrease in the number
of action potentials evoked by the ﬁxed-amplitude current
injection (Figure 4b). Like Mgþþ, TTX at 30, 60 and
90 nM decreased the number of spikes relative to baseline
(Figure 4).
In spite of these inhibitory effects of Mgþþ, we also
observed an unanticipated excitatory effect of Mgþþ. Mgþþ
depolarized neuronal resting Vm in a concentration-dependent manner (Figures 5a and b). This effect was associated
with an increased cellular input resistance (Figure 5c). To
deﬁne the approximate reversal potential of the current

Figure 3 Mgþþ increases voltage threshold for action potential initiation and decreases the number of spikes in response to prolonged current injection.
(a) Representative examples of action potentials elicited by a ﬁxed-amplitude current injection ( þ 120 pA) in whole-cell patch-clamp recordings. Action potential thresholds are
given for each trace, representing from left to right: 1 (baseline), 2.5, 5 and 10 mM additional MgCl2. See Figure 4 for summary data. (b) First derivative traces from the
examples shown in (a). Mgþþ reduced the maximum slope of action potentials (peak amplitude of the ﬁrst derivative), consistent with a reduction in availability of Na þ
channels. (c) Effects of Mgþþ on the number of action potentials elicited in response to a ﬁxed current injection. The examples are from the same recordings as in panels (a)
and (b). See Figure 4 for summary data
Cell Death and Disease
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Figure 4 Summary of cumulative data from whole-cell patch-clamp recordings.
(a) Left panel: action potential threshold suppression was dependent on Mgþþ
concentration. Right panel: TTX effects on action potential threshold were
comparable to those of Mgþþ. (b) Mgþþ decreased the number of spikes per
current injection. A concentration-dependent trend reached statistical signiﬁcance
with the highest concentration of Mgþþ. TTX again approximated the effect
of Mgþþ. (c) Action potential peak amplitude was unaffected by Mgþþ but
was signiﬁcantly reduced by TTX. (n ¼ 13 for Mgþþ-treated cells and 11 for
TTX-treated cells). **Po0.01; ***Po0.001

involved, we voltage-clamped cells and performed voltage
ramp protocols (Figure 5c). The change in slope of the current
response to the voltage ramp highlights the decrease in
membrane conductance in response to Mgþþ application.
Digital subtraction of the baseline response from the response
in the presence of Mgþþ suggested a strongly negative
reversal potential for the Mgþþ-sensitive current (84.8±
14.3 mV, n ¼ 6 cells). In one cell, we veriﬁed that reversal was
unaffected by increasing the pipette chloride concentration
to 140 mM (reversal potential for chloride (ECl) ¼ 0 mV). In
most cells, the Mgþþ-sensitive current showed apparent
inward rectiﬁcation (see example in Figure 5c). This could
suggest that Mgþþ blocks an inwardly rectifying current,
but we cannot exclude a voltage-dependent block of an
Ohmic conductance. As expected, TTX did not produce any
consistent change in resting Vm (63.4±2.4 mV versus

Figure 5 Mgþþ depolarizes neuronal resting potential. (a) Representative
example of the change in resting Vm just before current injection (arrow) with
escalating concentrations of Mgþþ. Each increase in Mgþþ concentration induced
an approximately 2 mV depolarization in resting Vm. (b) The bar graph represents
the cumulative change in Vm from all cellular recordings (n ¼ 13). There is
approximately a þ 5.2 mV shift in the mean Vm in control versus the high Mgþþ
group (11 mM total) *Po0.05; ***Po0.001. (c) Example voltage ramp performed
under baseline conditions and in the presence of 10 mM added Mgþþ (11 mM total).
The ramp was from 140 to 40 mV over 20 ms. Subtraction of a response in the
presence of Mgþþ from a control sweep produced a Mgþþ-sensitive current with
reversal potential of 84.8 mV in this cell

30 nM TTX: 63.7±3.7 mV). In summary, these experiments
suggest that Mgþþ inﬂuences resting potential primarily by
blocking a potassium conductance open at rest, possibly an
inwardly rectifying conductance.
In the context of our current-clamped cells bathed in
postsynaptic receptor antagonists, the inhibitory effects of
Mgþþ seemed to dominate the excitatory effect on resting
potential. However, the mixed effects of Mgþþ raise the
question of which effects would predominate in a spontaneously active network, such as in our survival studies. To
answer this question, we turned to multielectrode array (MEA)
recordings from our cultures (Figure 6). We used 30 nM TTX
Cell Death and Disease
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as a comparator because it approximated the increased
threshold of action potentials and decreased excitability
observed with the intermediate concentration of Mgþþ. When
the MEA cultures were bathed in recording saline containing
an additional 2.5 or 5 mM Mgþþ, a nearly complete silencing of
the neuronal network was observed (Figure 6). TTX at 30 nM,
similarly depressed network activity, with an almost complete
suppression of activity (Figure 6). In all cases, treatment
effects were compared against the average activity from
control and washout conditions to account for potential loss of
activity because of neuronal damage from repeated solution
exchanges. Activity levels in Mgþþ 2.5 mM, Mgþþ 5 mM and
TTX 30 nM were not signiﬁcantly different from each other and
all strongly and nearly completely suppressed network
activity. These results clearly suggest that inhibition is the
predominant effect of elevated extracellular Mgþþ in the intact
network.
Discussion

Figure 6 Mgþþ suppresses network activity. (a–c) Raster plots of MEA
recordings from control (a), Mgþþ 2.5 mM (b) and washout (c). The washout
recording was performed after the culture underwent recordings performed in the
Mgþþ 2.5 mM, Mgþþ 5 mM and TTX 30 nM treatment conditions. Although activity
was not as robust in the washout recordings, it was signiﬁcantly greater than in any
of the treatment conditions. The decrease in activity between baseline and washout
was likely due to incomplete TTX removal, and effects of repeated washes. Single
solution exchanges into the same medium had no effect on array-wide spike
detection (ASDR) rates. (d) Summary of activity levels in the treatment groups
showed as a fraction of ASDRs, expressed relative to the average of baseline and
washout ASDR rates. Nearly complete silencing of the neuronal network was
observed under all experimental treatments. (n ¼ 3 independent experiments).
**Po0.01

Cell Death and Disease

Although Mgþþ has complex effects on cellular excitability,
including both excitatory and inhibitory inﬂuences, our data
indicate that the overall inhibitory inﬂuence of Mgþþ accounts
for decreased neuronal survival with prolonged exposure. In
spite of a surprising depolarization of resting potential, the net
effect of Mgþþ is inhibitory, as shown by recordings of network
activity. Decreased excitability triggers neuronal death, and
depolarization with potassium protects against death. These
ﬁndings suggest that Mgþþ-induced neuronal apoptosis
in vivo25 likely results directly from the effects of Mgþþ on
susceptible neurons rather than through secondary consequences of systemic Mgþþ administration to animals. In
clinical obstetrics, Mgþþ administration is typically titrated
to maintain maternal serum levels of approximately 4–8 mg per 100 ml (1.6–3.3 mM). These concentrations are near the lowest concentrations that induced
signiﬁcant neuronal toxicity in our experiments.
Our present observations are also consistent with our
previous in vitro studies showing that depression of spontaneous activity of hippocampal neurons in vitro produces
apoptotic cell loss.28,29 Although the culture model has been
useful and generally correlates well with in vivo results, there
is at least one difference with in vivo neonatal studies that
merits mention. Activity-dependent cell loss in vitro has a
characteristically slower time course than observed in vivo.
In vitro loss takes 43 days, whereas markers of apoptosis
in vivo are observed within a few hours of treatment.34,35
Nevertheless, the in vitro model has been useful for identifying
and studying mechanistic details of apoptosis induced by
agents that suppress neuronal excitability in vivo.28,29
Endogenous magnesium maintains cell function, integrity,
and energy production, and extracellular Mgþþ modulates a
variety of different ion channels and receptors, including
NMDA receptors,10 Caþþ channels,36 GABAA receptors17
and voltage-gated channels.11,12,32 Manipulation of each of
these channel types has been shown to affect cell survival
during developmental synaptogenesis, when many neurons
undergo physiological cell death.31,34 The common theme
with apoptotic neuroactive agents, including Mgþþ, is that
neuronal activity is strongly suppressed. In susceptible,
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developing neurons activity suppression activates an apoptotic ‘trigger’. This common trigger could be reduced intracellular
Caþþ,30 but the trigger set-point can be inﬂuenced by
environmental factors.29
In spite of the variety of Mgþþ-sensitive targets that could
be relevant to effects on survival, our results suggest that
altered action potential initiation and sodium channel gating
are likely key to explaining survival effects. Our comparisons
with the selective sodium channel blocker TTX are the basis
for this conclusion. We have previously shown that TTX
silencing of neurons is sufﬁcient to cause apoptosis over
a similar time course to that observed here with Mgþþ. As
Mgþþ raises action potential threshold to values similar
to those achieved by TTX, and both have similar effects
on network excitability in MEA recordings, it is reasonable to
conclude that effects on Na þ channel gating and action
potential threshold primarily explain Mgþþ effects on excitability and survival, with little need to invoke mechanistic
explanations involving other channels (e.g., NMDA receptors
or Ca2 þ channels). If cells rarely reach action potential
threshold because of altered voltage-gated channel gating,
voltage-gated Caþþ channels will not open. Similarly, the
direct effect of Mgþþ on NMDA receptors will be largely
irrelevant in the absence of action potentials to drive
glutamate release. However, contributions from these other
inhibitory mechanisms cannot be completely excluded.
The effects on action potential threshold and network
excitability almost certainly result from classically described
effects of divalent cations on voltage-gated channels. Surface
charge screening effects by Mgþþ and by other divalent
cations have been described in numerous settings.11–14,32
This effect likely results from binding of extracellular divalent
cations to ﬁxed negative charges at the cellular membrane.32
This effectively reduces the surface potential and produces a
local hyperpolarizing inﬂuence on the voltage-sensitive
domains of channels. This charge screening effect is detected
as a depolarizing shift in voltage-dependent channel activation and inactivation. Classical work described the inﬂuence of
a multitude of divalent cations on excitability in nodes of
Ranvier of frog myelinated nerve ﬁbers; a 10-fold increase in
ion concentration shifts the ﬁring threshold up to þ 25 mV
depending on the ion.12 Speciﬁcally, an increase in Mgþþ from
1 to 10 mM shifts Na þ channel activation by approximately
þ 15 mV, coinciding with the approximately þ 13 mV shift in
action potential threshold observed in our experiments.
We also identiﬁed a potential excitatory effect of Mgþþ on
resting Vm. A rise in Mgþþ concentration from 1 to 10 mM
depolarized the resting Vm by 5.2 mV. To our knowledge, this
effect of Mgþþ has not been previously reported. Candidate
mechanisms based on the reversal potential of the Mgþþsensitive current include block of various ‘leak’ channels such
as inward rectifying K þ channels and 2-pore domain K þ
channels, such as Kir2.1 and TREK-1 K þ channels,
respectively.18,19 Although Mgþþ-induced depolarization
could, at face value, increase cell excitability, the surface
charge screening effects described above would prevent
signiﬁcant functional effects of the depolarization on excitability. The resting depolarization was smaller ( þ 5.2 mV)
than the expected shift in gating and steady state inactivation ( þ 13 mV) from surface charge effects (see above).

The inﬂuence of Mgþþ on resting Vm deserves further
exploration and could provide further understanding of the
contribution of ‘leak’ channels to the cellular resting Vm.
The use of Mgþþ in clinical obstetrics and neonatology as
an anticonvulsant, tocolytic and neuroprotectant is widespread, but studies supporting its clinical efﬁcacy are
controversial, and no studies have examined or established
the safety of its effects on normal, developing brains. Taken
together with our recent in vivo study,25 our results suggest
that developing neurons and neuronal networks require an
appropriate level of active input for proper development and
survival. Clinically relevant Mgþþ concentrations kill neurons
at this stage by dampening excitability and increasing
apoptosis. We observed Mgþþ-induced apoptotic cell death
in our previous in vivo studies, and this was supported by the
present in vitro experiments. Our experiments help link Mgþþ
to other neuro-depressive agents that promote apoptosis
in young neurons. Further studies are required to assess
the long-term effect of prenatal Mgþþ exposure on proper
neurocognitive and intellectual development.
Materials and Methods
Hippocampal cultures. Cultures were prepared using previously described
procedures.37 Brieﬂy, hippocampal cells were harvested from 1- to 3-day-postnatal
Sprague–Dawley rats. Slices (500–800 mm thick) of hippocampus were
enzymatically treated with 1 mg/ml papain in oxygenated Leibovitz’s L-15 medium
for 20–30 min. After transfer to Eagle’s minimal essential medium containing 5%
horse serum, 5% fetal calf serum, 17 mM D-glucose, 400 mM glutamine, 50 U/ml
penicillin and 50 mg/ml streptomycin, slices were gently triturated by passage
through Pasteur pipettes of decreasing diameter until a single-cell suspension of
approximately 300 000 cells/ml was obtained. Mass cultures were plated from this
suspension onto a collagen substrate (0.5 mg/ml rat tail, Sigma type I, St. Louis,
MO, USA), which was spread uniformly across a 35-mm plastic culture dish.38 At the
time cells were used for experiments (B7–15 days in vitro), mass culture neurons
were present at a density of approximately 500 cells/mm2. After 3 days in culture, all
cells were treated with 10 mM cytosine arabinoside to halt glial proliferation.
Survival and cell counts. To determine whether forebrain neurons are
sensitive to Mgþþ-induced cell death, we treated cultured hippocampal neurons for
6 days beginning at 5 days in vitro with various concentrations of MgSO4 or MgCl2.
Survival was assessed with counts of healthy neurons under phase-contrast optics
using an inverted microscope with a 20  objective. Ten random ﬁelds from sibling
culture dishes from the same plating were counted for surviving neurons. Cells were
counted as live if somas retained a smooth, phase-bright appearance with visible
processes. This is a protocol similar to that used by our group to show the neuronal
death in a comparable model.28,29 MgSO4 or MgCl2 were added directly to the
culture medium to initiate exposure and were incubated in a culture chamber with a
5% CO2 per air mixture at 371C.
Immunostaining. To assess if the neuronal death observed was apoptotic,
immunostaining for activated caspase-3 was performed. At 6 days in vitro, cultures
were treated with various concentrations of MgSO4 alone and in combination with
30 mM KCl. After 72 h of treatment, cultures were ﬁxed for 7 min in 4%
paraformaldehyde and 0.2% gluteraldehyde in phosphate-buffered saline. Cells
were permeablized with 0.1% Triton X-100, blocked with 10% serum, and incubated
for 4 h with caspase-3 antibody (Cell Signaling Technology, Danvers, CA, USA) at a
ﬁnal dilution of 1 : 1000. Cultures were then incubated in secondary antibody for
30 min, reacted in the dark with ABC reagents (Vector Laboratories, Burlingame,
CA, USA) for 10–15 min, then incubated in VIP peroxidase substrate for 2–4 min.
Healthy neurons and caspase-3-positive neurons were counted in 10 different ﬁelds
of the culture dish as described in the survival studies.
Electrophysiology. Conventional whole-cell patch clamping was employed
using an Axopatch 200B patch-clamp ampliﬁer and a Digidata 1322 acquisition
board (MDS, Sunnyvale, CA, USA). Recordings were obtained using pipettes
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of 7–8 MO open-tip resistance when ﬁlled with standard pipette solution containing
(in mM) K-gluconate (140), NaCl (4), CaCl2 (0.5), EGTA (5) and HEPES (10), and
pH adjusted to 7.25 with NaOH. At the time of experiments, culture medium was
replaced with an extracellular recording saline consisting of (in mM) NaCl (138), KCl
(4), CaCl2 (2.0), MgCl2 (1.0), glucose (10) and HEPES (10), and pH adjusted to 7.25
with KOH. D-2-amino-5-phosphonovalerate 50 mM, 2,3-dihydroxy-6-nitro-7sulfamoyl-benzo-quinoxaline-dione 1 mM and bicuculine 50 mM were added to the
extracellular solution to block NMDA, AMPA and GABA currents, respectively.
Pipette current offset in bath solution was adjusted to zero before gigaseal
formation. Pipette capacitance was compensated in the cell-attached conﬁguration.
On patch rupture, current-clamp circuitry was used. The initial resting Vm was set to
near 65 mV with a small bias current (if necessary) before initiating recordings.
Changes from this initial value were not subsequently compensated. Action
potentials were stimulated by current injection of þ 70 to þ 220 pA. Vm was
sampled at 50 kHz and low-pass ﬁltered at 10 kHz. MgCl2 and TTX were delivered
by local perfusion with a multi-barrel pipette positioned approximately 0.5 mm from
the cell of interest. Data were sampled and recorded using pCLAMP9 and analyzed
with Clampﬁt 9 software (MDS).
Multi-electrode array studies. MEAs were coated with poly-D-lysine and
laminin per the manufacturer’s instructions, and dispersed cultures were grown as
described above. At 7 and 10 days in vitro, one-third of the media was removed and
replaced with fresh Neurobasal supplemented with B27 and glutamine. Recordings
were made with the MEA-60 recording system (MultiChannel Systems, Reutlingen,
Germany) with the headstage in an incubator set at 29 1C and equilibrated with 5%
CO2 in room air with no additional humidity. The lower temperature was necessary
because the electronics in the headstage generate B71C of excess heat. The MEA
itself rested on a heating plate inside the headstage to maintain the cultures at
37 1C. To allow extended recordings in the dry incubator, cultures were covered with
a semipermeable membrane that allows diffusion of oxygen and carbon dioxide but
not water.39 The media in the MEA was replaced with the above described
extracellular recording saline (not including the synaptic blockers) and allowed to
re-equilibrate for approximately 5 min before recording. Data were ampliﬁed 1100
times and sampled at 5 kHz. Spikes were detected by threshold crossing of highpass ﬁltered data. The threshold was set individually for each contact at ﬁve S.D.
above the average RMS noise level. Baseline data were recorded in extracellular
recording saline. We then recorded activity in saline containing an additional 2.5 mM
Mgþþ, 5 mM Mgþþ, and 30 nM TTX. Finally, we collected another data set in the
original extracellular recording saline. All data sets were 30 min long.
Statistical analysis. For cell survival studies, cell counts were performed on at
least six independent experiments. For all experimental conditions tested, the
experimental groups were sibling culture dishes from the same culture plating matched
with a control dish containing baseline culture medium. A one-sample t-test was used
in which the mean for each experimental condition was compared with a theoretical
mean of 100% and reported as percent survival relative to control. For caspase-3
immunostaining, means for healthy cells and caspase-3-positive neurons were
determined from at least ﬁve independent experiments. The experimental conditions
and groups were tested as described above. Percent of caspase-3-positive to healthy
cells was calculated and a one-way analysis of variance (ANOVA) with either Tukey’s
or Dunett’s post hoc testing was used to compare the means of each experimental
condition. For electrophysiology studies, AP thresholds were measured from ﬁrst
derivative waveforms derived from the original action potential trace. Action potential
peak amplitude, resting Vm and number of action potential spikes per sweep were also
calculated. All electrophysiology data were analyzed with a repeated-measures
ANOVA, followed by Tukey’s post hoc analysis. For all experiments, the data were
analyzed for statistical signiﬁcance using Prism (GraphPad Software, Inc., La Jolla,
CA, USA). MEA data were quantiﬁed using the array-wide spike detection rate
(ASDR),40 deﬁned as the number of spikes detected in all contacts of the MEA during
each second of recording. The average ASDR for each 30-min data set was used as a
summary measure of activity. Activity during Mgþþ or TTX exposure was compared
with the average of the baseline and wash activity levels using a one-way ANOVA
followed by a post hoc Tukey’s test with Po0.05 considered signiﬁcant. Data from the
MEA experiments were analyzed in Igor Pro (Wavemetrics, Lake Oswego, OR, USA).

Conﬂict of interest
The authors declare no conﬂict of interest.
Cell Death and Disease

Acknowledgements. We thank A Taylor and A Benz for technical help and
laboratory members for advice and discussion. This work was supported by US
National Institutes of Health grants 5K08NS048113–04 (WHD), NS44041 (LNE),
NS54174 and MH78823 (SM), a grant from the Epilepsy Foundation of America
(LNE), and an NIH Neuroscience Blueprint Core Grant P30NS057105 to
Washington University.
Author Contributions: WHD, LNE and SM all participated in the conception and
design of the experiments, in collection, analysis and interpretation of data and in
writing and revising the paper.
1. Martin Jr JN, Thigpen BD, Moore RC, Rose CH, Cushman J, May W. Stroke and severe
preeclampsia and eclampsia: a paradigm shift focusing on systolic blood pressure.
Obstet Gynecol 2005; 105: 246–254.
2. Crowther CA, Hiller JE, Doyle LW. Magnesium sulphate for preventing preterm birth in
threatened preterm labour. Cochrane Database Syst Rev 2002 Art. no.: CD001060.
3. Lyell DJ, Pullen K, Campbell L, Ching S, Druzin ML, Chitkara U et al. Magnesium sulfate
compared with nifedipine for acute tocolysis of preterm labor: a randomized controlled trial.
Obstet Gynecol 2007; 110: 61–67.
4. Mittendorf R, Pryde PG. A review of the role for magnesium sulphate in preterm labour.
BJOG 2005; 112 (Suppl 1): 84–88.
5. Grimes DA, Nanda K. Magnesium sulfate tocolysis: time to quit. Obstet Gynecol 2006; 108:
986–989.
6. Ichiba H, Yokoi T, Tamai H, Ueda T, Kim TJ, Yamano T. Neurodevelopmental outcome of
infants with birth asphyxia treated with magnesium sulfate. Pediatr Int 2006; 48: 70–75.
7. Perlman JM. Intervention strategies for neonatal hypoxic-ischemic cerebral injury.
Clin Ther 2006; 28: 1353–1365.
8. Doyle LW, Crowther CA, Middleton P, Marret S. Antenatal magnesium sulfate and
neurologic outcome in preterm infants: a systematic review. Obstet Gynecol 2009; 113:
1327–1333.
9. Pryde PG, Mittendorf R. Contemporary usage of obstetric magnesium sulfate: indication,
contraindication, and relevance of dose. Obstet Gynecol 2009; 114: 669–673.
10. Mayer ML, Westbrook GL. Permeation and block of N-methyl-D-aspartic acid receptor
channels by divalent cations in mouse cultured central neurones. J Physiol 1987; 394:
501–527.
11. Frankenhaeuser B, Meves H. The effect of magnesium and calcium on the frog myelinated
nerve ﬁbre. J Physiol 1958; 142: 360–365.
12. Hille B, Woodhull AM, Shapiro BI. Negative surface charge near sodium channels of nerve:
divalent ions, monovalent ions, and pH. Philos Trans R Soc Lond B Biol Sci 1975; 270:
301–318.
13. Hahin R, Campbell DT. Simple shifts in the voltage dependence of sodium channel gating
caused by divalent cations. J Gen Physiol 1983; 82: 785–805.
14. Frankenhaeuser B, Hodgkin AL. The action of calcium on the electrical properties of squid
axons. J Physiol 1957; 137: 218–244.
15. Dodge Jr FA, Rahamimoff R. Co-operative action a calcium ions in transmitter release at
the neuromuscular junction. J Physiol 1967; 193: 419–432.
16. Fomin VP, Gibbs SG, Vanam R, Morimiya A, Hurd WW. Effect of magnesium sulfate on
contractile force and intracellular calcium concentration in pregnant human myometrium.
Am J Obstet Gynecol 2006; 194: 1384–1390.
17. Moykkynen T, Uusi-Oukari M, Heikkila J, Lovinger DM, Luddens H, Korpi ER. Magnesium
potentiation of the function of native and recombinant GABAA receptors. Neuroreport 2001;
12: 2175–2179.
18. Maingret F, Honore E, Lazdunski M, Patel AJ. Molecular basis of the voltage-dependent
gating of TREK-1, a mechano-sensitive K+channel. Biochem Biophys Res Commun 2002;
292: 339–346.
19. Murata Y, Fujiwara Y, Kubo Y. Identiﬁcation of a site involved in the block by extracellular Mg2+ and Ba2+ as well as permeation of K+ in the Kir2.1 K+ channel. J Physiol 2002;
544 (Pt 3): 665–677.
20. Slutsky I, Abumaria N, Wu LJ, Huang C, Zhang L, Li B et al. Enhancement of learning and
memory by elevating brain magnesium. Neuron 2010; 65: 165–177.
21. Ikonomidou C, Bosch F, Miksa M, Bittigau P, Vockler J, Dikranian K et al. Blockade of
NMDA receptors and apoptotic neurodegeneration in the developing brain. Science 1999;
283: 70–74.
22. Jevtovic-Todorovic V, Hartman RE, Izumi Y, Benshoff ND, Dikranian K, Zorumski CF et al.
Early exposure to common anesthetic agents causes widespread neurodegeneration in the
developing rat brain and persistent learning deﬁcits. J Neurosci 2003; 23: 876–882.
23. Turner CP, Miller R, Smith C, Brown L, Blackstone K, Dunham SR et al. Widespread
neonatal brain damage following calcium channel blockade. Dev Neurosci 2007; 29:
213–231.
24. Dobbing J, Sands J. Comparative aspects of the brain growth spurt. Early Hum Dev 1979;
3: 79–83.
25. Dribben WH, Creeley CE, Wang HH, Smith DJ, Farber NB, Olney JW. High dose
magnesium sulfate exposure induces apoptotic cell death in the developing neonatal
mouse brain. Neonatology 2009; 96: 23–32.
26. Mittendorf R, Covert R, Elin R, Pryde PG, Khoshnood B, Lee K. Umbilical cord serum
ionized magnesium level and total pediatric mortality. Obstet Gynecol 2001; 98: 75–78.

Mgþþ-induced apoptosis
WH Dribben et al

9
27. Young C, Tenkova T, Dikranian K, Olney JW. Excitotoxic versus apoptotic mechanisms of neuronal cell death in perinatal hypoxia/ischemia. Curr Mol Med 2004; 4:
77–85.
28. Moulder KL, Fu T, Melbostad H, Cormier RJ, Isenberg KE, Zorumski CF et al.
Ethanol-induced death of postnatal hippocampal neurons. Neurobiol Dis 2002; 10:
396–409.
29. Shute AA, Cormier RJ, Moulder KL, Benz A, Isenberg KE, Zorumski CF et al. Astrocytes
exert a pro-apoptotic effect on neurons in postnatal hippocampal cultures. Neuroscience
2005; 131: 349–358.
30. Franklin JL, Johnson Jr EM. Suppression of programmed neuronal death by sustained
elevation of cytoplasmic calcium. Trends Neurosci 1992; 15: 501–508.
31. Heck N, Golbs A, Riedemann T, Sun JJ, Lessmann V, Luhmann HJ. Activity-dependent
regulation of neuronal apoptosis in neonatal mouse cerebral cortex. Cereb Cortex 2008;
18: 1335–1349.
32. Hille B. Ion Channels of Excitable Membranes. 3rd edn Sinauer: Sunderland, MA, 2001.
xviii, 814 p.pp.
33. Meeks JP, Mennerick S. Action potential initiation and propagation in CA3 pyramidal
axons. J Neurophysiol 2007; 97: 3460–3472.
34. Olney JW, Wozniak DF, Jevtovic-Todorovic V, Farber NB, Bittigau P, Ikonomidou C.
Drug-induced apoptotic neurodegeneration in the developing brain. Brain Pathol 2002; 12:
488–498.

35. Xu W, Cormier R, Fu T, Covey DF, Isenberg KE, Zorumski CF et al. Slow death of postnatal
hippocampal neurons by GABAA receptor overactivation. J Neurosci 2000; 20: 3147–3156.
36. Hagiwara S, Takahashi K. Surface density of calcium ions and calcium spikes in the
barnacle muscle ﬁber membrane. J Gen Physiol 1967; 50: 583–601.
37. Mennerick S, Que J, Benz A, Zorumski CF. Passive and synaptic properties of
hippocampal neurons grown in microcultures and in mass cultures. J Neurophysiol 1995;
73: 320–332.
38. Zorumski CF, Thio LL, Clark GD, Clifford DB. Blockade of desensitization augments
quisqualate excitotoxicity in hippocampal neurons. Neuron 1990; 5: 61–66.
39. Potter SM, DeMarse TB. A new approach to neural cell culture for long-term studies.
J Neurosci Methods 2001; 110: 17–24.
40. Wagenaar DA, Pine J, Potter SM. An extremely rich repertoire of bursting patterns during
the development of cortical cultures. BMC Neurosci 2006; 7: 11.

Cell Death and Disease is an open-access journal
published by Nature Publishing Group. This work is
licensed under the Creative Commons Attribution-Noncommercial-No
Derivative Works 3.0 Unported License. To view a copy of this license,
visit http://creativecommons.org/licenses/by-nc-nd/3.0/

Cell Death and Disease

